Introduction: Sleep is normal human behaviour. However, the stress in daily life leads to altered sleep behaviour like insomnia, parasomnia, etc. Owing to possible side effects, mind-body interventions like music, yoga and meditation could be a better alternative intervention to pharmacological interventions for the condition. It is known that 432 Hz music to have some effect on the overall sleep quality though some knowledge gap does exist. The present study aims to find the effects of 432 Hz on sleep quality and sleep latency in a daytime nap among subjects with history of delayed sleep latency.

Material And Method: Fifteen healthy male volunteers aged 18 to 40 years with history of delayed sleep latency were recruited for the study from a cohort of working staff and students at the institute, after due ethical clearance following the inclusion and exclusion criteria. All the subjects were subjected to sleep study with and without music intervention at the gap of 1 week. Sleep parameters recorded include sleep stages, electroencephalogram (EEG), electrocardiogram (ECG), electromyography (EMG), nasal airflow, thoracic movement, nasal saturation etc.

Result: Outcome of the study shows some decrease in the mean sleep latency ( > 0.05) with significant increase in the energy of alpha waves ( < 0.01) at the sleep onset.

Conclusion: It was concluded that 432 Hz music has some significant calming effect as reflected by increased alpha activities without any significant effect upon the sleep latency in the daytime naps.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924256PMC
http://dx.doi.org/10.4103/jfmpc.jfmpc_575_19DOI Listing

Publication Analysis

Top Keywords

sleep latency
20
sleep
15
delayed sleep
12
latency daytime
12
daytime nap
8
432 music
8
sleep quality
8
history delayed
8
music
5
latency
5

Similar Publications

Duration of major depressive episodes and sleep architecture: an exploratory study.

J Psychiatr Res

December 2024

Vita-Salute San Raffaele University, Milan, Italy; Department of Clinical Neuroscience, Mood Disorders Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Growing evidence supports sleep-wake disruption as a mechanism involved in mood disorders pathogenesis. Duration of depressive episodes varies widely, and longer depressive episodes have been connected to worse outcomes. We aimed to explore if the length of depressive episodes is related to objective modifications of sleep features.

View Article and Find Full Text PDF

This study aimed to improve our understanding of sleep problems as a comorbidity of hereditary deaf-blindness due to Usher syndrome type 2a. Fifteen patients with Usher syndrome type 2a with a conclusive genetic diagnosis and 15 unaffected controls participated in comprehensive sleep and activity assessments for 2 weeks, using the MotionWatch 8 actigraph and consensus sleep diary. Various sleep parameters including sleep opportunity window, sleep latency, sleep efficiency, and self-reported sleep quality were analysed.

View Article and Find Full Text PDF

This study assessed the relationships among cognitive risk, phone use behaviors, and sleep quality. We used a questionnaire, which included the Pittsburgh Sleep Quality Index (PSQI), mobile phone use behaviours, and questionnaires on mobile phone use cognitive risk to gather information from 1204 college students. T-test, chi-square test, and Wilcoxon signed rank test were applied to test differences in measurement data.

View Article and Find Full Text PDF

Objectives: To explore the efficacy of ofatumumab in new onset narcolepsy type 1 following SARS-CoV-2 infection.

Methods: We present a 9-year-old girl who experienced new onset narcolepsy type 1 following SARS-CoV-2 infection. Polysomnography (PSG) followed by a daytime multiple sleep latency test (MSLT) was under taken after admission.

View Article and Find Full Text PDF

Developing a Sleep Algxorithm to Support a Digital Medicine System: Noninterventional, Observational Sleep Study.

JMIR Ment Health

December 2024

Otsuka Pharmaceutical Development & Commercialization, Inc, 508 Carnegie Center Drive, Princeton, NJ, 08540, United States, 1 609 535 9035.

Background: Sleep-wake patterns are important behavioral biomarkers for patients with serious mental illness (SMI), providing insight into their well-being. The gold standard for monitoring sleep is polysomnography (PSG), which requires a sleep lab facility; however, advances in wearable sensor technology allow for real-world sleep-wake monitoring.

Objective: The goal of this study was to develop a PSG-validated sleep algorithm using accelerometer (ACC) and electrocardiogram (ECG) data from a wearable patch to accurately quantify sleep in a real-world setting.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!